AKT1 and triple-negative breast carcinoma: CPNE1 may promote tumorigenesis and radioresistance of triple-negative breast cancer (TNBC) through AKT pathway activation and so target expression of CPNE1 could be a good strategy to sensitize TNBC to radiotherapy [15].